$2.440
+0.242 (+9.91%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Alterity Therapeutics Limited (ATHE) Moving Averages Convergence Divergence (MACD) indicator is -0.28, suggesting ATHE is Sell.
Alterity Therapeutics Limited (ATHE) 20-Day simple moving average is 2.39, while Alterity Therapeutics Limited (ATHE) share price is $—, making it Buy.
Alterity Therapeutics Limited (ATHE) 60-Day simple moving average is 3.49, while Alterity Therapeutics Limited (ATHE) share price is $—, making it Sell.
Technical Analysis for ATHE
AI Technical ATHEAs of 2026-11-03, the technical board for Alterity Therapeutics Limited (ATHE) reads sell: 4 indicators are flashing buy, 5 are indicating sell, and 4 are neutral. Price at $2.44 sits below the 60-day and 200-day moving averages and above the 5-day, 10-day and 20-day.
Momentum readings: RSI stands at 43.345, MACD stands at -0.277 (Sell), Stochastic %K stands at 27.617, Stochastic %D stands at 27.128 and CCI stands at -7.921.
ATHE trades below the 60-day SMA (3.49) and below the 200-day SMA (3.96). Immediate resistance sits at Classic R1 3.02, then R2 3.79. Support sits at Classic S1 1.74, then S2 1.23.
Alterity Therapeutics Limited (ATHE) Support & Resistance Level
Alterity Therapeutics Limited (ATHE) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 43.345 |
| STOCHk_14_3_3 | 27.617 |
| STOCHd_14_3_3 | 27.128 |
| CCI_20 | -7.921 |
| AO_5_34 | -0.462 |
| MOM_10 | 0.340 |
| MACD_12_26_9 | -0.277 |
Alterity Therapeutics Limited (ATHE) Relative Strength Index (RSI_14) is 43.345, creating a Neutral signal.
Alterity Therapeutics Limited (ATHE) Stochastic %K is 27.617, creating a Neutral signal.
Alterity Therapeutics Limited (ATHE) Stochastic %D is 27.128, creating a Neutral signal.
Alterity Therapeutics Limited (ATHE) CCI_20 is -7.921, creating a Neutral signal.
Alterity Therapeutics Limited (ATHE) Awesome Oscillator (AO) is -0.462, creating a Sell signal.
Alterity Therapeutics Limited (ATHE) Momentum (MOM) is 0.340, creating a Buy signal.
Alterity Therapeutics Limited (ATHE) Moving Average Convergence Divergence (MACD) is -0.277, creating a Sell signal.
Alterity Therapeutics Limited (ATHE) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 2.330 | Buy |
| MA_10 | 2.243 | Buy |
| MA_20 | 2.390 | Buy |
| MA_60 | 3.493 | Sell |
| MA_200 | 3.955 | Sell |
| MA_250 | 3.836 | Sell |
Alterity Therapeutics Limited (ATHE) 5-Day simple moving average is 2.330, while Alterity Therapeutics Limited (ATHE) share price is $, making it a Buy.
Alterity Therapeutics Limited (ATHE) 10-Day simple moving average is 2.243, while Alterity Therapeutics Limited (ATHE) share price is $, making it a Buy.
Alterity Therapeutics Limited (ATHE) 20-Day simple moving average is 2.390, while Alterity Therapeutics Limited (ATHE) share price is $, making it a Buy.
Alterity Therapeutics Limited (ATHE) 60-Day simple moving average is 3.493, while Alterity Therapeutics Limited (ATHE) share price is $, making it a Sell.
Alterity Therapeutics Limited (ATHE) 200-Day simple moving average is 3.955, while Alterity Therapeutics Limited (ATHE) share price is $, making it a Sell.
Alterity Therapeutics Limited (ATHE) 250-Day simple moving average is 3.836, while Alterity Therapeutics Limited (ATHE) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.